Historical Valuation
Treace Medical Concepts Inc (TMCI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.75 is considered Undervalued compared with the five-year average of -31.14. The fair price of Treace Medical Concepts Inc (TMCI) is between 9.86 to 34.75 according to relative valuation methord. Compared to the current price of 2.90 USD , Treace Medical Concepts Inc is Undervalued By 70.6%.
Relative Value
Fair Zone
9.86-34.75
Current Price：2.90
70.6%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Treace Medical Concepts Inc (TMCI) has a current Price-to-Book (P/B) ratio of 1.79. Compared to its 3-year average P/B ratio of 6.33 , the current P/B ratio is approximately -71.78% higher. Relative to its 5-year average P/B ratio of 2.93, the current P/B ratio is about -39.07% higher. Treace Medical Concepts Inc (TMCI) has a Forward Free Cash Flow (FCF) yield of approximately -16.54%. Compared to its 3-year average FCF yield of -7.73%, the current FCF yield is approximately 113.87% lower. Relative to its 5-year average FCF yield of -5.64% , the current FCF yield is about 193.38% lower.
P/B
Median3y
6.33
Median5y
2.93
FCF Yield
Median3y
-7.73
Median5y
-5.64
Competitors Valuation Multiple
AI Analysis for TMCI
The average P/S ratio for TMCI competitors is 5.43, providing a benchmark for relative valuation. Treace Medical Concepts Inc Corp (TMCI.O) exhibits a P/S ratio of 0.75, which is -86.13% above the industry average. Given its robust revenue growth of 11.37%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for TMCI
1Y
3Y
5Y
Market capitalization of TMCI increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of TMCI in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is TMCI currently overvalued or undervalued?
Treace Medical Concepts Inc (TMCI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.75 is considered Undervalued compared with the five-year average of -31.14. The fair price of Treace Medical Concepts Inc (TMCI) is between 9.86 to 34.75 according to relative valuation methord. Compared to the current price of 2.90 USD , Treace Medical Concepts Inc is Undervalued By 70.60% .
What is Treace Medical Concepts Inc (TMCI) fair value?
TMCI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Treace Medical Concepts Inc (TMCI) is between 9.86 to 34.75 according to relative valuation methord.
How does TMCI's valuation metrics compare to the industry average?
The average P/S ratio for TMCI's competitors is 5.43, providing a benchmark for relative valuation. Treace Medical Concepts Inc Corp (TMCI) exhibits a P/S ratio of 0.75, which is -86.13% above the industry average. Given its robust revenue growth of 11.37%, this premium appears unsustainable.
What is the current P/B ratio for Treace Medical Concepts Inc (TMCI) as of Jan 10 2026?
As of Jan 10 2026, Treace Medical Concepts Inc (TMCI) has a P/B ratio of 1.79. This indicates that the market values TMCI at 1.79 times its book value.
What is the current FCF Yield for Treace Medical Concepts Inc (TMCI) as of Jan 10 2026?
As of Jan 10 2026, Treace Medical Concepts Inc (TMCI) has a FCF Yield of -16.54%. This means that for every dollar of Treace Medical Concepts Inc’s market capitalization, the company generates -16.54 cents in free cash flow.
What is the current Forward P/E ratio for Treace Medical Concepts Inc (TMCI) as of Jan 10 2026?
As of Jan 10 2026, Treace Medical Concepts Inc (TMCI) has a Forward P/E ratio of -2.83. This means the market is willing to pay $-2.83 for every dollar of Treace Medical Concepts Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Treace Medical Concepts Inc (TMCI) as of Jan 10 2026?
As of Jan 10 2026, Treace Medical Concepts Inc (TMCI) has a Forward P/S ratio of 0.75. This means the market is valuing TMCI at $0.75 for every dollar of expected revenue over the next 12 months.